Mentions
Extended reach
Total likes
Video views
AI synopsis
Several discussions emphasize the significance of the study, mentioning key statistics such as '87.8% of patients with COVID-19 and ARDS have lupus anticoagulant' and comparing them to non-COVID ARDS. The language used, along with terms like 'game changer' and 'high risk,' strongly conveys the urgency and importance of the findings, reflecting both concern and a push for revised clinical protocols.
Most discussions express support for the findings regarding the increased risk of thrombosis in COVID-19 patients.
There is a marked curiosity about the study's implications, with many participants highlighting its relevance.
The discussions delve deeply into the study details, including specific statistics on thrombotic complications and comparisons with non-COVID ARDS.
Participants widely believe the study significantly affects clinical practices in treating severe COVID-19 cases, emphasizing its potential to change patient outcomes.
87.8% of patients with #COVID19 and ARDS have lupus anticoagulant. They also have more pulmonary embolism than those patients with ARDS without #covid19 (11.7% vs 2.1%, p<0.008). This is despite 100% of these patients being anticoagulated. https://t.co/qItNW6jmpF https://t.co/baZ6e9PKP5
Review of cohort study showing clinically relevant/life-threatening thrombotic complications detected in #COVID19 #ARDS pts during #ICU stay (mainly PE 16.7%) despite anticoagulation; higher targets probably to be considered! #COVIDFOAM @yourICM https://t.co/0I0tmj8t6b @macromik https://t.co/EbdpiUmEWI https://t.co/nUivkDmQYi
https://t.co/DlpbZLF58u
4⃣High risk of thrombosis in pts with severe #SARSCoV2 https://t.co/Dp10mBs0zJ 5⃣#COVID19 pneumonia: different respiratory treatments for different phenotypes? https://t.co/InvCuYTwJw 6⃣ Findings of lung #ultrasonography of #coronavirus pneumonia https://t.co/bV57xSHSvN https://t.co/4tXbVXOqyx
sources: https://t.co/Z9GdFLbK9i https://t.co/jGMEYn8Lhu https://t.co/NyXSDYMueM https://t.co/xrtvLhGcKF
@DrMCecconi et al were amongst the first to notice the increased risk of thrombosis https://t.co/DtqZicCWsR
This video discusses the thrombotic complications associated with COVID-19, particularly in patients suffering from severe acute respiratory distress syndrome (ARDS). It highlights research indicating that heightened…
This video discusses the elevated risk of thrombotic complications in COVID-19 patients with severe acute respiratory distress syndrome (ARDS). The study highlights the need for enhanced anticoagulation strategies to…
@FagaReinaldo @JulimarGomes1 @Dr_Francisco_ https://t.co/AW51QPrpFo
RT @koureiigaku: パンデミック波の中では第1波のCOVID-19急性期のリスクが特に高く、これは特に第1波後の血栓予防治療の普及によって説明できます。 さらにより重症な入院、特に集中治療室入院患者はリスクが極めて高く、血栓予防治療をしてもなお高いことが示されまし…
パンデミック波の中では第1波のCOVID-19急性期のリスクが特に高く、これは特に第1波後の血栓予防治療の普及によって説明できます。 さらにより重症な入院、特に集中治療室入院患者はリスクが極めて高く、血栓予防治療をしてもなお高いことが示されました。 https://t.co/gDJDiZDh7H
RT @dscharpfMD: https://t.co/DlpbZLF58u
RT @dscharpfMD: https://t.co/DlpbZLF58u
https://t.co/XVN0ri9OAx
https://t.co/DlpbZLF58u
@Schreiberine @EichholtzAlex https://t.co/DlpbZLnugW
@ghurabaa_786 @Calvin489 @MissCapricorn73 @TPostMillennial Here’s a report of thrombosis from Covid. Notice it’s from just 4 hospitals and had worse outcomes. Your statistic is worldwide. https://t.co/7hNCFte3MR
@nrittes @JosAvelino9 @Alenetopf @monicabergamo O risco de trombose é muito maior em pacientes com Covid do que o verificado em estudos com a vacina (https://t.co/A8JOX6Dmmh) Como a vacina não previne o contágio, as chances de você ter uma trombose causada pela Covid são ordens de magnitude maior do que causada pela vacina.
RT @MatejKolarich: @tasosedova Dvomim, da je že kakšna slovenska raziskava. Morda poglej podatke iz te: https://t.co/k17UVrtwOe Tukaj so pr…
RT @MatejKolarich: @tasosedova Dvomim, da je že kakšna slovenska raziskava. Morda poglej podatke iz te: https://t.co/k17UVrtwOe Tukaj so pr…
@tasosedova Dvomim, da je že kakšna slovenska raziskava. Morda poglej podatke iz te: https://t.co/k17UVrtwOe Tukaj so primerjali ljudi, ki fašejo ARDS (acute respiratory distress syndrome) zaradi korone ali pa zaradi kake druge bolezni. 11.7% (COVID) vs. 2.1% (non-COVID). It's obvious. 1/2
RT @VWHORUSHD: @VPrasadMDMPH @matthewherper Fair enough but limiting the comparison to just *arterial* thrombotic complications for COVID p…
@VPrasadMDMPH @matthewherper Fair enough but limiting the comparison to just *arterial* thrombotic complications for COVID pts, it's still much more dangerous to get COVID than the J&J or AZ vaccines. COVID clotting isn't limited to DVTs https://t.co/mBy6NmEXDZ https://t.co/9LTV15XXR2 https://t.co/qmLEGuQS2i
@RenaudDouze @PtiteRapporteuZ (Clinical Research in Intensive Care and Sepsis Trial Group for Global Evaluation and Research in Sepsis). High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020 Jun;46(6):1089-1098.
RT @yourICM: 4⃣High risk of thrombosis in pts with severe #SARSCoV2 https://t.co/Dp10mBs0zJ 5⃣#COVID19 pneumonia: different respiratory tr…
RT @yourICM: 4⃣High risk of thrombosis in pts with severe #SARSCoV2 https://t.co/Dp10mBs0zJ 5⃣#COVID19 pneumonia: different respiratory tr…
RT @yourICM: 4⃣High risk of thrombosis in pts with severe #SARSCoV2 https://t.co/Dp10mBs0zJ 5⃣#COVID19 pneumonia: different respiratory tr…
RT @yourICM: 4⃣High risk of thrombosis in pts with severe #SARSCoV2 https://t.co/Dp10mBs0zJ 5⃣#COVID19 pneumonia: different respiratory tr…
RT @yourICM: 4⃣High risk of thrombosis in pts with severe #SARSCoV2 https://t.co/Dp10mBs0zJ 5⃣#COVID19 pneumonia: different respiratory tr…
RT @yourICM: 4⃣High risk of thrombosis in pts with severe #SARSCoV2 https://t.co/Dp10mBs0zJ 5⃣#COVID19 pneumonia: different respiratory tr…
RT @yourICM: 4⃣High risk of thrombosis in pts with severe #SARSCoV2 https://t.co/Dp10mBs0zJ 5⃣#COVID19 pneumonia: different respiratory tr…
RT @yourICM: 4⃣High risk of thrombosis in pts with severe #SARSCoV2 https://t.co/Dp10mBs0zJ 5⃣#COVID19 pneumonia: different respiratory tr…
RT @yourICM: 4⃣High risk of thrombosis in pts with severe #SARSCoV2 https://t.co/Dp10mBs0zJ 5⃣#COVID19 pneumonia: different respiratory tr…
4⃣High risk of thrombosis in pts with severe #SARSCoV2 https://t.co/Dp10mBs0zJ 5⃣#COVID19 pneumonia: different respiratory treatments for different phenotypes? https://t.co/InvCuYTwJw 6⃣ Findings of lung #ultrasonography of #coronavirus pneumonia https://t.co/bV57xSHSvN https://t.co/4tXbVXOqyx
RT @yourICM: Review of cohort study showing clinically relevant/life-threatening thrombotic complications detected in #COVID19 #ARDS pts du…
RT @yourICM: Review of cohort study showing clinically relevant/life-threatening thrombotic complications detected in #COVID19 #ARDS pts du…
RT @yourICM: Review of cohort study showing clinically relevant/life-threatening thrombotic complications detected in #COVID19 #ARDS pts du…
RT @yourICM: Review of cohort study showing clinically relevant/life-threatening thrombotic complications detected in #COVID19 #ARDS pts du…
RT @yourICM: Review of cohort study showing clinically relevant/life-threatening thrombotic complications detected in #COVID19 #ARDS pts du…
RT @yourICM: Review of cohort study showing clinically relevant/life-threatening thrombotic complications detected in #COVID19 #ARDS pts du…
RT @yourICM: Review of cohort study showing clinically relevant/life-threatening thrombotic complications detected in #COVID19 #ARDS pts du…
Review of cohort study showing clinically relevant/life-threatening thrombotic complications detected in #COVID19 #ARDS pts during #ICU stay (mainly PE 16.7%) despite anticoagulation; higher targets probably to be considered! #COVIDFOAM @yourICM https://t.co/0I0tmj8t6b @macromik https://t.co/EbdpiUmEWI https://t.co/nUivkDmQYi
RT @Tigerariel40: High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study https://t.co…
High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study https://t.co/Tzl8RpKX92
sources: https://t.co/Z9GdFLbK9i https://t.co/jGMEYn8Lhu https://t.co/NyXSDYMueM https://t.co/xrtvLhGcKF
RT @CMichaelGibson: 87.8% of patients with #COVID19 and ARDS have lupus anticoagulant. They also have more pulmonary embolism than those p…
RT @WesElyMD: CLOTS & #Covid 2: https://t.co/tXGWgyDYAT ICM article to accompany yesterday’s CCM in tweet below. N=150, 15X ⬆️❗️PEs vs nonC…
Todays article: High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multi-centre prospective cohort study
Alto riesgo de Trombosis en pacientes con covid19. Estudio https://t.co/B2aBpXcVDG
RT @DrSamuelBrown: Some early data, slightly more rigorous than before, about thrombotic complications in COVID. https://t.co/ZfsmfzixK9 Ab…
Some early data, slightly more rigorous than before, about thrombotic complications in COVID. https://t.co/ZfsmfzixK9 About 15% rate of PE. The rest isn't obviously happening very much. Comparison to prior ARDS cohort is helpful but ascertainment bias is a big problem. How much
RT @WesElyMD: CLOTS & #Covid 2: https://t.co/tXGWgyDYAT ICM article to accompany yesterday’s CCM in tweet below. N=150, 15X ⬆️❗️PEs vs nonC…
@SharonEFoxMD @smlungpathguy Many studies now reporting coagulaopathy associated with #Covid19 such as “High Risk of Thrombosis in Patients With Severe SARS-CoV-2 Infection: A Multicenter Prospective Cohort Study” https://t.co/6T50LhBrEY
RT @CMichaelGibson: 87.8% of patients with #COVID19 and ARDS have lupus anticoagulant. They also have more pulmonary embolism than those p…
RT @CMichaelGibson: 87.8% of patients with #COVID19 and ARDS have lupus anticoagulant. They also have more pulmonary embolism than those p…
RT @CMichaelGibson: 87.8% of patients with #COVID19 and ARDS have lupus anticoagulant. They also have more pulmonary embolism than those p…
RT @CMichaelGibson: 87.8% of patients with #COVID19 and ARDS have lupus anticoagulant. They also have more pulmonary embolism than those p…
RT @CMichaelGibson: 87.8% of patients with #COVID19 and ARDS have lupus anticoagulant. They also have more pulmonary embolism than those p…
RT @CMichaelGibson: 87.8% of patients with #COVID19 and ARDS have lupus anticoagulant. They also have more pulmonary embolism than those p…
RT @CMichaelGibson: 87.8% of patients with #COVID19 and ARDS have lupus anticoagulant. They also have more pulmonary embolism than those p…
RT @CMichaelGibson: 87.8% of patients with #COVID19 and ARDS have lupus anticoagulant. They also have more pulmonary embolism than those p…
RT @CMichaelGibson: 87.8% of patients with #COVID19 and ARDS have lupus anticoagulant. They also have more pulmonary embolism than those p…
RT @CMichaelGibson: 87.8% of patients with #COVID19 and ARDS have lupus anticoagulant. They also have more pulmonary embolism than those p…
RT @CMichaelGibson: 87.8% of patients with #COVID19 and ARDS have lupus anticoagulant. They also have more pulmonary embolism than those p…
RT @CMichaelGibson: 87.8% of patients with #COVID19 and ARDS have lupus anticoagulant. They also have more pulmonary embolism than those p…
RT @CMichaelGibson: 87.8% of patients with #COVID19 and ARDS have lupus anticoagulant. They also have more pulmonary embolism than those p…
RT @CMichaelGibson: 87.8% of patients with #COVID19 and ARDS have lupus anticoagulant. They also have more pulmonary embolism than those p…
RT @CMichaelGibson: 87.8% of patients with #COVID19 and ARDS have lupus anticoagulant. They also have more pulmonary embolism than those p…
RT @CMichaelGibson: 87.8% of patients with #COVID19 and ARDS have lupus anticoagulant. They also have more pulmonary embolism than those p…
RT @CMichaelGibson: 87.8% of patients with #COVID19 and ARDS have lupus anticoagulant. They also have more pulmonary embolism than those p…
RT @CMichaelGibson: 87.8% of patients with #COVID19 and ARDS have lupus anticoagulant. They also have more pulmonary embolism than those p…
RT @CMichaelGibson: 87.8% of patients with #COVID19 and ARDS have lupus anticoagulant. They also have more pulmonary embolism than those p…
RT @CMichaelGibson: 87.8% of patients with #COVID19 and ARDS have lupus anticoagulant. They also have more pulmonary embolism than those p…
RT @CMichaelGibson: 87.8% of patients with #COVID19 and ARDS have lupus anticoagulant. They also have more pulmonary embolism than those p…
RT @CMichaelGibson: 87.8% of patients with #COVID19 and ARDS have lupus anticoagulant. They also have more pulmonary embolism than those p…
RT @CMichaelGibson: 87.8% of patients with #COVID19 and ARDS have lupus anticoagulant. They also have more pulmonary embolism than those p…
RT @CMichaelGibson: 87.8% of patients with #COVID19 and ARDS have lupus anticoagulant. They also have more pulmonary embolism than those p…
RT @CMichaelGibson: 87.8% of patients with #COVID19 and ARDS have lupus anticoagulant. They also have more pulmonary embolism than those p…
RT @CMichaelGibson: 87.8% of patients with #COVID19 and ARDS have lupus anticoagulant. They also have more pulmonary embolism than those p…
RT @CMichaelGibson: 87.8% of patients with #COVID19 and ARDS have lupus anticoagulant. They also have more pulmonary embolism than those p…
RT @CMichaelGibson: 87.8% of patients with #COVID19 and ARDS have lupus anticoagulant. They also have more pulmonary embolism than those p…
RT @CMichaelGibson: 87.8% of patients with #COVID19 and ARDS have lupus anticoagulant. They also have more pulmonary embolism than those p…
RT @CMichaelGibson: 87.8% of patients with #COVID19 and ARDS have lupus anticoagulant. They also have more pulmonary embolism than those p…
RT @CMichaelGibson: 87.8% of patients with #COVID19 and ARDS have lupus anticoagulant. They also have more pulmonary embolism than those p…
RT @CMichaelGibson: 87.8% of patients with #COVID19 and ARDS have lupus anticoagulant. They also have more pulmonary embolism than those p…
RT @CMichaelGibson: 87.8% of patients with #COVID19 and ARDS have lupus anticoagulant. They also have more pulmonary embolism than those p…
RT @CMichaelGibson: 87.8% of patients with #COVID19 and ARDS have lupus anticoagulant. They also have more pulmonary embolism than those p…
RT @CMichaelGibson: 87.8% of patients with #COVID19 and ARDS have lupus anticoagulant. They also have more pulmonary embolism than those p…
RT @CMichaelGibson: 87.8% of patients with #COVID19 and ARDS have lupus anticoagulant. They also have more pulmonary embolism than those p…
RT @CMichaelGibson: 87.8% of patients with #COVID19 and ARDS have lupus anticoagulant. They also have more pulmonary embolism than those p…
RT @CMichaelGibson: 87.8% of patients with #COVID19 and ARDS have lupus anticoagulant. They also have more pulmonary embolism than those p…
RT @CMichaelGibson: 87.8% of patients with #COVID19 and ARDS have lupus anticoagulant. They also have more pulmonary embolism than those p…
RT @CMichaelGibson: 87.8% of patients with #COVID19 and ARDS have lupus anticoagulant. They also have more pulmonary embolism than those p…
RT @CMichaelGibson: 87.8% of patients with #COVID19 and ARDS have lupus anticoagulant. They also have more pulmonary embolism than those p…
RT @CMichaelGibson: 87.8% of patients with #COVID19 and ARDS have lupus anticoagulant. They also have more pulmonary embolism than those p…
RT @CMichaelGibson: 87.8% of patients with #COVID19 and ARDS have lupus anticoagulant. They also have more pulmonary embolism than those p…
RT @CMichaelGibson: 87.8% of patients with #COVID19 and ARDS have lupus anticoagulant. They also have more pulmonary embolism than those p…
RT @CMichaelGibson: 87.8% of patients with #COVID19 and ARDS have lupus anticoagulant. They also have more pulmonary embolism than those p…
RT @CMichaelGibson: 87.8% of patients with #COVID19 and ARDS have lupus anticoagulant. They also have more pulmonary embolism than those p…
RT @CMichaelGibson: 87.8% of patients with #COVID19 and ARDS have lupus anticoagulant. They also have more pulmonary embolism than those p…
RT @CMichaelGibson: 87.8% of patients with #COVID19 and ARDS have lupus anticoagulant. They also have more pulmonary embolism than those p…
RT @CMichaelGibson: 87.8% of patients with #COVID19 and ARDS have lupus anticoagulant. They also have more pulmonary embolism than those p…
RT @CMichaelGibson: 87.8% of patients with #COVID19 and ARDS have lupus anticoagulant. They also have more pulmonary embolism than those p…
RT @CMichaelGibson: 87.8% of patients with #COVID19 and ARDS have lupus anticoagulant. They also have more pulmonary embolism than those p…
RT @CMichaelGibson: 87.8% of patients with #COVID19 and ARDS have lupus anticoagulant. They also have more pulmonary embolism than those p…
RT @CMichaelGibson: 87.8% of patients with #COVID19 and ARDS have lupus anticoagulant. They also have more pulmonary embolism than those p…
RT @CMichaelGibson: 87.8% of patients with #COVID19 and ARDS have lupus anticoagulant. They also have more pulmonary embolism than those p…
87.8% of patients with #COVID19 and ARDS have lupus anticoagulant. They also have more pulmonary embolism than those patients with ARDS without #covid19 (11.7% vs 2.1%, p<0.008). This is despite 100% of these patients being anticoagulated. https://t.co/qItNW6jmpF https://t.co/baZ6e9PKP5
RT @WesElyMD: CLOTS & #Covid 2: https://t.co/tXGWgyDYAT ICM article to accompany yesterday’s CCM in tweet below. N=150, 15X ⬆️❗️PEs vs nonC…
RT @WesElyMD: CLOTS & #Covid 2: https://t.co/tXGWgyDYAT ICM article to accompany yesterday’s CCM in tweet below. N=150, 15X ⬆️❗️PEs vs nonC…
RT @iceman_ex: @DrMCecconi et al were amongst the first to notice the increased risk of thrombosis https://t.co/DtqZicCWsR
@DrMCecconi et al were amongst the first to notice the increased risk of thrombosis https://t.co/DtqZicCWsR
RT @WesElyMD: CLOTS & #Covid 2: https://t.co/tXGWgyDYAT ICM article to accompany yesterday’s CCM in tweet below. N=150, 15X ⬆️❗️PEs vs nonC…
RT @WesElyMD: CLOTS & #Covid 2: https://t.co/tXGWgyDYAT ICM article to accompany yesterday’s CCM in tweet below. N=150, 15X ⬆️❗️PEs vs nonC…
RT @WesElyMD: CLOTS & #Covid 2: https://t.co/tXGWgyDYAT ICM article to accompany yesterday’s CCM in tweet below. N=150, 15X ⬆️❗️PEs vs nonC…
RT @WesElyMD: CLOTS & #Covid 2: https://t.co/tXGWgyDYAT ICM article to accompany yesterday’s CCM in tweet below. N=150, 15X ⬆️❗️PEs vs nonC…
Publicación High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study https://t.co/Jsn9WJ2HRk #Hemostasia #Trombosis #Recursos
High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study https://t.co/2HtFfNQjHd
#High Risk of Thrombosis in Patients With Severe SARS-CoV-2 Infection: A Multicenter Prospective Cohort Study. #COVID19 #Latestresearch #Mustread #Submityourpaper at https://t.co/dVryE4BVnm or send to email id nanomedicine@emedicalsciences.com #Source: https://t.co/SjqZnIkYoQ
RT @CtdGrupo: High risk of thrombosis in patients with severe #SARS_CoV_2 infection: a multicenter prospective cohort study https://t.co/i…
High risk of thrombosis in patients with severe #SARS_CoV_2 infection: a multicenter prospective cohort study https://t.co/idhPtnIeAd
Altmetric – High risk of thrombosis in patients with severe SARS-CoV-2… https://t.co/RTqRXyYAfZ
High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study | SpringerLink Be aware of blood clots in covid19!! https://t.co/awZU9UN1Hg
High risk of #thrombosis in patients with severe #SARS-CoV-2 infection: a multicenter prospective cohort study https://t.co/FcoYhAdg1Y
RT @lasecip: High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study https://t.co/ciIV…
High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study https://t.co/ciIVi3SY8S #IntCareMed